KR850002103A - 세팔로스포린의 제조방법 - Google Patents

세팔로스포린의 제조방법 Download PDF

Info

Publication number
KR850002103A
KR850002103A KR1019840005717A KR840005717A KR850002103A KR 850002103 A KR850002103 A KR 850002103A KR 1019840005717 A KR1019840005717 A KR 1019840005717A KR 840005717 A KR840005717 A KR 840005717A KR 850002103 A KR850002103 A KR 850002103A
Authority
KR
South Korea
Prior art keywords
group
mentioned
aryl
general formula
aralkyl
Prior art date
Application number
KR1019840005717A
Other languages
English (en)
Other versions
KR870001291B1 (ko
Inventor
다까시 나가이 (외 5)
Original Assignee
나까노 다다오
도야마 가가꾸 고교 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나까노 다다오, 도야마 가가꾸 고교 가부시끼 가이샤 filed Critical 나까노 다다오
Publication of KR850002103A publication Critical patent/KR850002103A/ko
Application granted granted Critical
Publication of KR870001291B1 publication Critical patent/KR870001291B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

내용없음

Description

세팔로스포린의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 하기 일반식(Ⅱ)의 화합물을 삼플루오로화 붕소 또는 이의 착화합물 존재하에서 하기 일반식(Ⅲ)의 화합물과 반응시키고, 필요하다면, 카복실-보호기를 제거하거나 상기의 생성물을 염으로 전환시킴을 특징으로 하여, 하기 일반식(Ⅰ)의 세팔로스포린 또는 이의 염을 제조하는 방법.
    상기 식에서, R1은 치환되거나 비치환된 알킬, 아르알킬 또는 아릴기이고; R5는 카복실-보호기이고; R5a는 수소원자 또는 카복실-보호기이고; R6은 수소원자, 할로겐원자, 저급알킬기 또는 일반식-CH2R7의 기(여기서, R7는 히드록실기, 또는 치환되거나 비치환된 아실옥시, 카바모일옥시, 아실아미노, 아릴, 복소환식티오, 방향족 복소환식기 또는 복소환식기이며, 언급된 방향족 복소환식기는 탄소-탄소 결합을 통해세펨고리의 3-위치에서 엑소메틸렌기에 결합되고, 언급된 복소환식기는 탄소-질소결합을 통해 세펨고리의 3-위치에서 엑소메틸렌기에 결합된다)이고;-A-는 메틸렌기 또는 일반식의 기[여기서 R2는 수소원자; 치환되거나 비치환된 알킬, 알케닐, 알키닐 시클로알킬, 시클로알케닐, 아르알킬, 아릴 또는 복소환식기; 히드록시-보호기; 또는 일반식의 기(여기서 R3및 R4는 동일하거나 다를 수 있으며, 히드록실, 알킬, 아르알킬, 아릴, 알콕시, 아르알킬옥시 또는 아릴옥시 기이다)이고, 결합은 신(syn)- 또는 안티(anti)-이성체를 나타내거나 이의 혼합물을 나타낸다]이다.
  2. 제1항에 있어서, 언급된 R1이 비치환된 알킬기인 방법.
  3. 제1항에 있어서, 언급된 R1이 비치환된 아릴기인 방법.
  4. 제1 내지 3항중 어느 하나에 있어서, 언급된 -A-가 일반식의 기(여기서 R2및 결합은 전술한 바와 같다)인 방법.
  5. 제1 내지 4항중 어느 하나에 있어서, 언급된 반응을 유기용매의 존재하에서 수행하는 방법.
  6. 제1 내지 5항중 어느 하나에 있어서, 언급된 반응을 0° 내지 100℃의 온도에서 수행하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840005717A 1983-09-20 1984-09-19 세팔로 스포린의 제조방법 KR870001291B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP83-172254/83 1983-09-20
JP58172254A JPS6064986A (ja) 1983-09-20 1983-09-20 セファロスポリン類の製造法
JP172254/83 1983-09-20

Publications (2)

Publication Number Publication Date
KR850002103A true KR850002103A (ko) 1985-05-06
KR870001291B1 KR870001291B1 (ko) 1987-07-11

Family

ID=15938478

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840005717A KR870001291B1 (ko) 1983-09-20 1984-09-19 세팔로 스포린의 제조방법

Country Status (33)

Country Link
US (1) US4614819A (ko)
JP (1) JPS6064986A (ko)
KR (1) KR870001291B1 (ko)
AR (1) AR240823A1 (ko)
AT (1) AT385757B (ko)
AU (1) AU566674B2 (ko)
BE (1) BE900636A (ko)
CA (1) CA1229847A (ko)
CH (1) CH662120A5 (ko)
CS (1) CS249522B2 (ko)
DD (1) DD226894A5 (ko)
DE (1) DE3434096A1 (ko)
DK (1) DK445984A (ko)
EG (1) EG16497A (ko)
ES (1) ES8506728A1 (ko)
FI (1) FI77039C (ko)
FR (1) FR2552088B1 (ko)
GB (1) GB2148282B (ko)
HU (1) HU192449B (ko)
IL (1) IL72965A (ko)
IN (1) IN160019B (ko)
IT (1) IT1178434B (ko)
LU (1) LU85543A1 (ko)
MX (1) MX157789A (ko)
NL (1) NL8402871A (ko)
NO (1) NO164903C (ko)
NZ (1) NZ209605A (ko)
PH (1) PH20463A (ko)
PL (1) PL145900B1 (ko)
PT (1) PT79233A (ko)
RO (1) RO89362A (ko)
SE (1) SE463421B (ko)
ZA (1) ZA847276B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
US4618606A (en) * 1982-11-17 1986-10-21 Toyama Chemical Co., Ltd. Antibiotic 7-(thiazolyl)-3-(pyrazinylmethyl) or (pyridazinylmethyl) cephalosporins
EP0156771A3 (en) * 1984-03-29 1986-03-19 Biochemie Gesellschaft M.B.H. Cephalosporins
DK500285A (da) * 1984-11-02 1986-05-03 Glaxo Group Ltd Cephalosporinantibiotika
US4675398A (en) * 1985-08-16 1987-06-23 E. R. Squibb & Sons, Inc. Copper-mediated oximation reaction
IE862850L (en) * 1985-11-21 1987-05-21 Inst Animal Health Ltd Intermediates for the preparation of beta-lactam antibiotics
US4728733A (en) * 1985-11-25 1988-03-01 American Home Products Corporation C-3' thiadiazinyl cephalosporin analogs
US4728732A (en) * 1985-11-25 1988-03-01 American Home Products Corporation C-3'acylsulfonamido cephalosporin analogs
US4728734A (en) * 1985-11-25 1988-03-01 American Home Products Corporation C-3'thioiminosulfonyl cephalosporin analogs
JPH064643B2 (ja) * 1985-12-20 1994-01-19 ファイザー製薬株式会社 セフアロスポリン化合物
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
EP0269298B1 (en) * 1986-11-21 1994-10-19 Ici Pharma Cephalosporins, process for their preparation and pharmaceutical compositions
DE3750673T2 (de) * 1986-11-21 1995-03-16 Ici Pharma Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
JPH02191285A (ja) * 1988-06-28 1990-07-27 Ajinomoto Co Inc アミド化合物の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533719B2 (ko) 1973-01-13 1980-09-02
US4299829A (en) * 1976-03-12 1981-11-10 Fujisawa Pharmaceutical Co., Ltd. 2-Lower alkyl-7-substituted-2 or 3-cephem 4-carboxylic acid compounds
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
EP0004570B1 (en) * 1978-03-09 1982-04-14 Asahi Kasei Kogyo Kabushiki Kaisha Thiol esters, process for their preparation, pharmaceutical compositions containing them and a process for preparing cephalosporin compounds using the same
NO801501L (no) * 1979-05-23 1980-11-24 Rhone Poulenc Ind Fremgangsmaate for fremstilling av 3-tiovinylcefalosporiner
NL8100539A (nl) * 1980-02-12 1981-09-01 Rhone Poulenc Ind Nieuwe thiolesters, de bereiding daarvan en hun gebruik bij syntheses.
JPS56135488A (en) * 1980-03-26 1981-10-22 Asahi Chem Ind Co Ltd Novel preparative method of cephalosporanic acid derivative
CY1365A (en) * 1980-03-28 1987-08-07 Biochemie Gmbh New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
EP0061234A3 (en) * 1981-03-05 1983-11-16 Beecham Group Plc Cephalosporin derivatives, process for their preparation and pharmaceutical preparations containing them
FI75827C (fi) * 1982-11-17 1988-08-08 Toyama Chemical Co Ltd Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart 7-tiazolyl-3-pyrazinylmetylcefalosporin samt en i foerfarandet anvaendbar mellanprodukt.

Also Published As

Publication number Publication date
IT8448880A0 (it) 1984-09-19
JPH0320397B2 (ko) 1991-03-19
FI77039C (fi) 1989-01-10
MX157789A (es) 1988-12-15
PL249671A1 (en) 1985-06-18
KR870001291B1 (ko) 1987-07-11
PH20463A (en) 1987-01-14
PL145900B1 (en) 1988-11-30
IT1178434B (it) 1987-09-09
ATA297584A (de) 1987-10-15
FR2552088B1 (fr) 1988-05-27
DK445984D0 (da) 1984-09-19
FI843622A0 (fi) 1984-09-17
GB8423158D0 (en) 1984-10-17
AT385757B (de) 1988-05-10
DE3434096A1 (de) 1985-03-28
AU566674B2 (en) 1987-10-29
FI77039B (fi) 1988-09-30
LU85543A1 (fr) 1985-04-29
ES536070A0 (es) 1985-07-16
NO164903B (no) 1990-08-20
EG16497A (en) 1987-04-30
FI843622L (fi) 1985-03-21
IL72965A0 (en) 1984-12-31
AR240823A1 (es) 1991-02-28
SE8404700L (sv) 1985-03-21
AR240823A2 (es) 1991-02-28
ZA847276B (en) 1985-05-29
HUT35686A (en) 1985-07-29
NO843732L (no) 1985-03-21
AU3291184A (en) 1985-03-28
SE463421B (sv) 1990-11-19
CS249522B2 (en) 1987-03-12
GB2148282B (en) 1987-03-11
NO164903C (no) 1990-11-28
IN160019B (ko) 1987-06-20
DD226894A5 (de) 1985-09-04
HU192449B (en) 1987-06-29
GB2148282A (en) 1985-05-30
SE8404700D0 (sv) 1984-09-19
JPS6064986A (ja) 1985-04-13
NL8402871A (nl) 1985-04-16
NZ209605A (en) 1987-04-30
PT79233A (en) 1984-10-01
CA1229847A (en) 1987-12-01
DK445984A (da) 1985-03-21
RO89362A (ro) 1986-05-30
IL72965A (en) 1989-01-31
FR2552088A1 (fr) 1985-03-22
ES8506728A1 (es) 1985-07-16
US4614819A (en) 1986-09-30
CH662120A5 (de) 1987-09-15
BE900636A (fr) 1985-03-20

Similar Documents

Publication Publication Date Title
KR850002103A (ko) 세팔로스포린의 제조방법
KR860001104A (ko) 테트라히드로프탈이미드의 제조방법
KR900009593A (ko) 2-클로로피리딘 3-카르복실산 에스테르 제조 방법
KR830007503A (ko) 신규트리아민유도체의 제조방법 및 이 유도체를 함유하는 수지조성물
KR840006338A (ko) 4-옥소-1,4-디하이드로 니코틴산 유도체의 제조방법
KR920008018A (ko) 피페라진 유도체의 제조방법
KR850001184A (ko) 1,5-벤조티아제핀 유도체의 제조방법
KR840007882A (ko) 디히드로피리딘 유도체 및 그 제법
KR860001065A (ko) 4-아세톡시-3-히드록시에틸아제티진-2-온유도체의 제조방법
KR850007604A (ko) 샤르트류신 유도체 또는 그 염의 제조방법
KR830007655A (ko) 벤조디아제핀 화합물의 제조 방법
KR850008173A (ko) 세팔로 스포린 및 그의 제조 중간체의 제조방법
KR840004065A (ko) 2-시아노-2-프로페노산 및 그 유도체의 제조방법
KR850004460A (ko) 인돌의 제조방법
KR840006234A (ko) 1,3-디티안류의 제조방법
KR870004104A (ko) 플루오란 유도체와 그의 제조방법 및 그를 함유하는 기록물질
KR840005723A (ko) 티아졸유도체의 제조방법
KR830005122A (ko) 1-아릴옥시-3-알킬아미노-2-프로판올류의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR850002095A (ko) 4,7-디히드로피라졸로[3,4-b] 피리딘 유도체의 제조방법
KR830006293A (ko) 신규 폴리아자 헤테로고리 화합물의 제조방법
KR850001742A (ko) 큐말산 에스테르의 제조방법
KR850000034A (ko) 테트라하이드로-β-카르보린 유도체의 제조방법
KR850006420A (ko) 세팔로스포린의 제조방법
KR830009055A (ko) 치환된 페닐설포닐우레아 유도체 및 그의 중간물질의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970618

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee